| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 65.76% | 63.11% | 35.39% | 12.50% | 7 | -27.10% | 2025-06-24 |
| 2 | 阳景 | 浦银国际证券 | 医药生物 | 65.71% | 36.24% | 8.11% | 100.00% | 4 | 0.00% | 2025-10-27 |
| 3 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 65.71% | 65.15% | 38.40% | 12.50% | 7 | -27.10% | 2025-06-26 |
| 4 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 60.08% | 9.36% | -2.86% | 0 | -56.96% | 2025-07-22 |
| 5 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 39.79% | 0.00% | -2.86% | 0 | -56.96% | 2025-09-17 |
| 6 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 23.01% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-12 |
| 7 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 68.98% | 42.97% | -2.86% | 0 | -56.96% | 2025-07-07 |
| 8 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 14.04% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-17 |
| 9 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 40.50% | 0.00% | -2.86% | 0 | -56.96% | 2025-09-26 |
| 10 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 37.43% | 0.00% | -2.86% | 0 | -56.96% | 2025-09-23 |
| 11 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 18.35% | 0.00% | -2.86% | 0 | -56.96% | 2025-11-14 |
| 12 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 10.95% | 0.00% | -2.86% | 0 | -56.96% | 2025-10-30 |
| 13 | 李安飞 | 广发证券 | 医药生物 | 65.70% | 67.80% | 21.18% | -2.86% | 0 | -56.96% | 2025-07-02 |
| 14 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 0.00% | 0.00% | -2.86% | 0 | -56.96% | 2025-12-24 |
| 15 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 61.62% | 19.60% | -2.86% | 0 | -56.96% | 2025-08-07 |
| 16 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 48.59% | 15.14% | -2.86% | 0 | -56.96% | 2025-08-22 |
| 17 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 39.24% | 6.55% | -2.86% | 0 | -56.96% | 2025-09-01 |
| 18 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 38.59% | 0.00% | -2.86% | 0 | -56.96% | 2025-09-25 |
| 19 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 27.68% | 0.00% | -2.86% | 0 | -56.96% | 2025-10-13 |
| 20 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 34.98% | 0.00% | -2.86% | 0 | -56.96% | 2025-10-16 |